Details
Zusammenfassung: <jats:title>Abstract</jats:title> <jats:p>Molecular profiling in thyroid cancer has made significant progress in part due to advances in somatic mutation profiling. Yet, differentiating benign from malignant thyroid nodules remains elusive. A unique set of DNA methylation signatures has the potential of improving thyroid cancer molecular diagnostics based on the DNA methylome.</jats:p> <jats:p>See related article by Yim et al., p. 544</jats:p>
Umfang: 457-459
ISSN: 1078-0432
1557-3265
DOI: 10.1158/1078-0432.ccr-18-2820